Webinar: On the brink of commercialisation – Watch on demand
A Watson Marlow Fluid Technology Solutions webinar with insights from NIBRT’s Training Director John Milne
Title: On the brink of commercialisation – Addressing the challenges of commercialisation for cell and gene therapies/ATMPs
Duration: 58 minutes
Delivery: On Demand
Many novel cell and gene therapies (CGTs) are now entering the commercialization stage but, as developers look to recoup investment and quickly deliver life-saving therapies to the patients that need them, they face a myriad of challenges.
In this webinar, learn how advanced therapy medicinal product (ATMP) platforms, using single-use systems, are delivering streamlined, efficient and cost-effective manufacturing solutions in this dynamic sector.
Key discussion points include:
- The key attributes of ATMP platforms that deliver efficient manufacturing.
- The importance of developing process design around single-use systems.
- Training to meet the skills challenge
- Case studies using modular ATMP platforms.